XML 86 R21.htm IDEA: XBRL DOCUMENT
v3.20.1

SEGMENT AND GEOGRAPHIC INFORMATION | 3 Months Ended
--- | ---
Mar. 31, 2020
Segment Reporting [Abstract] |
SEGMENT AND GEOGRAPHIC INFORMATION | SEGMENT AND GEOGRAPHIC INFORMATION The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.
• | The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.
• | The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.
The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs. The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by each reportable segment for the three months ended March 31, 2020 and 2019 are as follows:
| Three Months Ended March 31,
| 2020 |  | 2019
| (In thousands)
Segment Net Sales |  |  |
Codman Specialty Surgical | $ | 231,440 |  |  | $ | 234,568 |
Orthopedics and Tissue Technologies | 122,884 |  |  | 125,122 |
Total revenues | $ | 354,324 |  |  | $ | 359,690 |
Segment Profit |  |  |
Codman Specialty Surgical | $ | 87,235 |  |  | $ | 91,380 |
Orthopedics and Tissue Technologies | 31,271 |  |  | 40,495 |
Segment profit | 118,506 |  |  | 131,875 |
Amortization | (6,977 | ) |  | (5,279) |
Corporate and other | (84,426 | ) |  | (94,288 | )
Operating income | $ | 27,103 |  |  | $ | 32,308 |
The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment. The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:
| Three Months Ended March 31,
| 2020 |  | 2019
| (In thousands)
United States | $ | 246,852 |  |  | $ | 256,726 |
Europe | 45,896 |  |  | 48,640 |
Asia Pacific | 39,960 |  |  | 35,700 |
Rest of World | 21,616 |  |  | 18,624 |
Total Revenues | $ | 354,324 |  |  | $ | 359,690 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration